logo
Share SHARE
FONT-SIZE Plus   Neg

Onyx Pharma Loss Widens In Q1

Onyx Pharmaceuticals, Inc. (ONXX: Quote) Wednesday reported a first-quarter loss of $56.2 million or $0.88 per share, which widened from $49.2 million or $0.78 per share in the same period last year.

Adjusted loss for the period was $43.5 million or $0.68 per share, compared to $14.2 million or $0.23 per share last year.

On average, 12 analysts polled by Thomson Reuters expected a loss of $0.63 per share for the first quarter. Analysts' estimates typically exclude special items.

First-quarter revenues increased 7 percent to $72.0 million from $67.1 million last year. Analysts expected revenues of $70.04 million for the period.

Operating expenses for the period totaled $122.8 million, up from $108.5 million last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
If calories are not reduced, exercise alone can have no effect on obesity, says British Sports Medicine, a peer-reviewed journal of sport and exercise medicine. The journal says the blame for expanding waist lines is directly on the type and amount of calories consumed and the poor diet generates more disease than physical inactivity, alcohol and smoking combined. Deutsche Bank (DB) on Sunday reported an about 50 percent decline in first-quarter profit, despite clocking double-digit revenue growth, as the German lender recorded hefty legal charges over allegations of rate-rigging. Casino operator Wynn Resorts said its shareholders ousted Elaine Wynn from the board, reflecting fears that her presence may lead to disharmony with the management.
comments powered by Disqus
Follow RTT